Results 111 to 120 of about 15,884 (195)

Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response? [PDF]

Clinical and Molecular Hepatology, 2020
Byoung Kuk Jang
doaj   +1 more source

Evaluación de la costo-efectividad de entecavir versus lamivudina en pacientes con hepatitis B crónica

Acta Gastroenterológica Latinoamericana, 2008
La infección crónica por el virus de la hepatitis B representa una importante carga de enfermedad en el mundo y en Argentina. Existen nuevas estrategias terapéuticas, entre ellas el entecavir, un análogo nucleósido.
Juan Ignacio Calcagno, Federico Augustovski, Adrián Gadano, Alberto Souto, Yong Yuan   +4 more
doaj  

Intracranial hepatitis B virus (HBV) infection following intracerebral hemorrhage in a patient with seronegative occult HBV infection. [PDF]

IDCases
Ji X, Wang M, Jin P, Kong L, Xu Y, Chen W, Liu B, Wang Q.   +7 more
europepmc   +1 more source

Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis. [PDF]

Pak J Med Sci
Zuberi BF, Ali FS, Rasheed T, Bader N.
europepmc   +1 more source

Entecavir provides favorable virological control but minimal metabolic benefit in patients with Chronic Hepatitis B and MAFLD. [PDF]

Am J Transl Res
Wang B, Mo X, Wu X, Huang Y, Deng K, Liang Y, Lu Z, Wei H, Liang J, Huang Z.   +9 more
europepmc   +1 more source

Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B. [PDF]

World J Hepatol
Ma SP, Wang L, Zhang YL, Wan X, Liu Q, Tang YL, Malhi LR, Ge SF.   +7 more
europepmc   +1 more source

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand [PDF]

, 2014

core   +1 more source

A Rare Case of Myopathy Associated with Entecavir Initiation. [PDF]

J Pharm Technol
Overton C, Brock L, Betapudi B, Wells DA.   +3 more
europepmc   +1 more source

Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. [PDF]

Mediterr J Hematol Infect Dis
Silva N, Duarte G, Medina S, Amarante GD, de Souza CA, Pagnano K.   +5 more
europepmc   +1 more source

Genotype-specific Response to 144-week Entecavir Therapy for HBeAg-positive Chronic Hepatitis B with a Particular Focus on Histological Improvement: A Prospective Study. [PDF]

J Clin Transl Hepatol
Liu L, Xu Q, Lin S, Wei Z, Huang G.
europepmc   +1 more source